Clinical Trials
NDA-Enabling Study Guide
Altasciences' specialists apply their decades of experience in designing, conducting, analyzing, and reporting on trials for regulatory submissions, across the spectrum of therapeutic areas. Unclear as to which studies may be required? Download our complimentary fact sheet or click below to learn more about the requirements for each study type. |
|
Safety Tolerability and Pharmacokinetics of GIC-1001 Following Multiple Ascending Doses Administrations Through an Adaptive First-in-Human Study in Healthy Volunteers
Cognitive Performance and Psychedelic Effects Following Single and Multiple Ascending Doses of a New Cannabis Formulation
Microsampling - Making a Difference in Drug Development
Microsampling volume
Blood microsampling is a less invasive and simplified alternative to traditional venipuncture, and provides significant ad
Altasciences Fills Need of Leading Cancer Therapeutic Drug Developer
Microsampling Benefits
Choosing the Right CRO for Your Clinical Trial Monitoring
At Altasciences, we understand your clinical trials are unique and require careful management. As part of our partnership with you, our highly experienced CRAs offer top quality monitoring, through agile and flexible processes and transparent communication. We are up to date with all required trainings, and remain abreast of current legislations, techniques, and technologies. For more information on Altasciences' monitoring capabilities, contact one of our experienced CRA team members. |
The Right Strategy for your Small Molecule Program
Polyvalent Human Immune Globulin: A Prospective, Open-Label Study Assessing Anti-Hepatitis A Virus (HAV) Antibody Levels, Pharmacokinetics, and Safety in HAV-Seronegative Healthy Subjects
Evaluation of the abuse potential of pitolisant, a selective H3-receptor antagonist/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexy